Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 2
2019 4
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Compensatory role of insulin-like growth factor 1 receptor in estrogen receptor signaling pathway and possible therapeutic target for hormone therapy-resistant breast cancer.
Iida M, Tsuboi K, Niwa T, Ishida T, Hayashi SI. Iida M, et al. Among authors: tsuboi k. Breast Cancer. 2019 May;26(3):272-281. doi: 10.1007/s12282-018-0922-0. Epub 2018 Oct 16. Breast Cancer. 2019. PMID: 30328006
Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.
Uchiumi K, Tsuboi K, Sato N, Ito T, Hirakawa H, Niwa T, Yamaguchi Y, Hayashi SI. Uchiumi K, et al. Among authors: tsuboi k. Breast Cancer. 2019 Jul;26(4):459-470. doi: 10.1007/s12282-018-00944-1. Epub 2019 Jan 4. Breast Cancer. 2019. PMID: 30610551
Decreased ER dependency after acquired resistance to CDK4/6 inhibitors.
Iida M, Toyosawa D, Nakamura M, Tsuboi K, Tokuda E, Niwa T, Ishida T, Hayashi SI. Iida M, et al. Among authors: tsuboi k. Breast Cancer. 2020 Sep;27(5):963-972. doi: 10.1007/s12282-020-01090-3. Epub 2020 Apr 15. Breast Cancer. 2020. PMID: 32297248
Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer.
Kimura M, Hanamura T, Tsuboi K, Kaneko Y, Yamaguchi Y, Niwa T, Narui K, Endo I, Hayashi SI. Kimura M, et al. Among authors: tsuboi k. Oncotarget. 2018 Apr 20;9(30):21468-21477. doi: 10.18632/oncotarget.25133. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765553 Free PMC article.
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer.
Guo Z, Tada H, Kitamura N, Hamada Y, Miyashita M, Harada-Shoji N, Sato A, Hamanaka Y, Tsuboi K, Harada N, Takano-Kasuya M, Okada H, Nakano Y, Ohuchi N, Hayashi SI, Ishida T, Gonda K. Guo Z, et al. Among authors: tsuboi k. Cancers (Basel). 2019 Apr 12;11(4):526. doi: 10.3390/cancers11040526. Cancers (Basel). 2019. PMID: 31013810 Free PMC article.
Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K, Kaneko Y, Nagatomo T, Fujii R, Hanamura T, Gohno T, Yamaguchi Y, Niwa T, Hayashi SI. Tsuboi K, et al. J Steroid Biochem Mol Biol. 2017 Mar;167:115-125. doi: 10.1016/j.jsbmb.2016.11.017. Epub 2016 Nov 22. J Steroid Biochem Mol Biol. 2017. PMID: 27888136
Single CpG site methylation controls estrogen receptor gene transcription and correlates with hormone therapy resistance.
Tsuboi K, Nagatomo T, Gohno T, Higuchi T, Sasaki S, Fujiki N, Kurosumi M, Takei H, Yamaguchi Y, Niwa T, Hayashi SI. Tsuboi K, et al. J Steroid Biochem Mol Biol. 2017 Jul;171:209-217. doi: 10.1016/j.jsbmb.2017.04.001. Epub 2017 Apr 12. J Steroid Biochem Mol Biol. 2017. PMID: 28412323
Feedback